Article (Published version) (94 Kb) - 
Limited access to UNIGE
Highlights
Scientific Article
unige:42126 
 |
High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion |
|
| Authors | ||
| Published in | Journal of Clinical Pharmacy and Therapeutics. 2004, vol. 29, no. 4, p. 351-7 | |
| Abstract | To compare the efficacy, ease of use and safety of intermittent vancomycin infusion (IVI) and continuous vancomycin infusion (CVI) in high-dose therapy of osteomyelitis. | |
| Keywords | Anti-Bacterial Agents/adverse effects/pharmacokinetics/therapeutic use — Humans — Infusions, Intravenous/methods — Methicillin Resistance — Osteomyelitis/drug therapy/microbiology — Staphylococcal Infections/drug therapy — Treatment Outcome — Vancomycin/adverse effects/pharmacokinetics/therapeutic use | |
| Identifiers | PMID: 15271102 | |
| Full text | ||
| Structures | ||
| Research group | Chirurgie orthopédique et traumatologique (98) | |
| Citation (ISO format) | VUAGNAT, A et al. High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion. In: Journal of Clinical Pharmacy and Therapeutics, 2004, vol. 29, n° 4, p. 351-7. doi: 10.1111/j.1365-2710.2004.00572.x https://archive-ouverte.unige.ch/unige:42126 |
361 hits 
0 download 
Contact an author
Update